87 results on '"LaRocque, Regina C."'
Search Results
2. Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection.
- Author
-
Roach, David J, Sridhar, Sushmita, Oliver, Elizabeth, Rao, Sowmya R, Slater, Damien M, Hwang, Wontae, Vater, Kian Hutt, Dinesh, Anupama, Qadri, Firdausi, Chisti, Mohammod J, Pierce, Virginia M, Turbett, Sarah E, Bhattacharyya, Roby P, Worby, Colin J, Earl, Ashlee M, LaRocque, Regina C, and Harris, Jason B
- Subjects
BACTEREMIA ,KLEBSIELLA ,SEQUENCE analysis ,CONFIDENCE intervals ,MANN Whitney U Test ,ACQUISITION of data ,KLEBSIELLA infections ,RISK assessment ,HOSPITAL mortality ,T-test (Statistics) ,GENOMES ,SYMPTOMS ,RESEARCH funding ,DESCRIPTIVE statistics ,CHI-squared test ,MEDICAL records ,DRUG resistance in microorganisms ,DATA analysis software ,ODDS ratio ,LOGISTIC regression analysis ,MICROBIAL virulence - Abstract
Background The clinical and microbial factors associated with Klebsiella pneumoniae bloodstream infections (BSIs) are not well characterized. Prior studies have focused on highly resistant or hypervirulent isolates, limiting our understanding of K. pneumoniae strains that commonly cause BSI. We performed a record review and whole-genome sequencing to investigate the clinical characteristics, bacterial diversity, determinants of antimicrobial resistance, and risk factors for in-hospital death in a cohort of patients with K. pneumoniae BSI. Methods We identified 562 patients at Massachusetts General Hospital with K. pneumoniae BSIs between 2016 and 2022. We collected data on comorbid conditions, infection source, clinical outcomes, and antibiotic resistance and performed whole-genome sequencing on 108 sequential BSI isolates from 2021 to 2022. Results Intra-abdominal infection was the most common source of infection accounting for 34% of all BSIs. A respiratory tract source accounted for 6% of BSIs but was associated with a higher in-hospital mortality rate (adjusted odds ratio, 5.4 [95% confidence interval, 2.2–12.8]; P <.001 for comparison with other sources). Resistance to the first antibiotic prescribed was also associated with a higher risk of death (adjusted odds ratio, 5.2 [95% confidence interval, 2.2–12.4]; P <.001). BSI isolates were genetically diverse, and no clusters of epidemiologically and genetically linked cases were observed. Virulence factors associated with invasiveness were observed at a low prevalence, although an unexpected association between O-antigen type and the source of infection was found. Conclusions These observations demonstrate the versatility of K. pneumoniae as an opportunistic pathogen and highlight the need for new approaches for surveillance and the rapid identification of patients with invasive antimicrobial-resistant K. pneumoniae infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.
- Author
-
Kaisar, M. Hasanul, Kelly, Meagan, Kamruzzaman, Mohammad, Bhuiyan, Taufiqur R., Chowdhury, Fahima, Khan, Ashraful Islam, LaRocque, Regina C., Calderwood, Stephen B., Harris, Jason B., Charles, Richelle C., Čížová, Alžbeta, Mečárová, Jana, Korcová, Jana, Bystrický, Slavomír, Kováč, Pavol, Peng Xu, Qadri, Firdausi, and Ryan, Edward T.
- Published
- 2023
- Full Text
- View/download PDF
4. Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers.
- Author
-
Brown, David Garrett, Worby, Colin J, Pender, Melissa A, Brintz, Ben J, Ryan, Edward T, Sridhar, Sushmita, Oliver, Elizabeth, Harris, Jason B, Turbett, Sarah E, Rao, Sowmya R, Earl, Ashlee M, LaRocque, Regina C, and Leung, Daniel T
- Subjects
RECEIVER operating characteristic curves ,CLINICAL prediction rules ,PREDICTION models ,BETA lactam antibiotics ,FEATURE selection - Abstract
Background Extended spectrum beta-lactamase producing Enterobacterales (ESBL-PE) present a risk to public health by limiting the efficacy of multiple classes of beta-lactam antibiotics against infection. International travellers may acquire these organisms and identifying individuals at high risk of acquisition could help inform clinical treatment or prevention strategies. Methods We used data collected from a cohort of 528 international travellers enrolled in a multicentre US-based study to derive a clinical prediction rule (CPR) to identify travellers who developed ESBL-PE colonization, defined as those with new ESBL positivity in stool upon return to the United States. To select candidate features, we used data collected from pre-travel and post-travel questionnaires, alongside destination-specific data from external sources. We utilized LASSO regression for feature selection, followed by random forest or logistic regression modelling, to derive a CPR for ESBL acquisition. Results A CPR using machine learning and logistic regression on 10 features has an internally cross-validated area under the receiver operating characteristic curve (cvAUC) of 0.70 (95% confidence interval 0.69–0.71). We also demonstrate that a four-feature model performs similarly to the 10-feature model, with a cvAUC of 0.68 (95% confidence interval 0.67–0.69). This model uses traveller's diarrhoea, and antibiotics as treatment, destination country waste management rankings and destination regional probabilities as predictors. Conclusions We demonstrate that by integrating traveller characteristics with destination-specific data, we could derive a CPR to identify those at highest risk of acquiring ESBL-PE during international travel. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Knowledge, attitudes and practices regarding the use of mobile travel health apps.
- Author
-
Machoko, Munashe M P, Dong, Yinan, Grozdani, Andonaq, Hong, Hung, Oliver, Elizabeth, Hyle, Emily P, Ryan, Edward T, Colubri, Andrés, and LaRocque, Regina C
- Subjects
NAVIGATION & travel mobile apps ,SCIENTIFIC literature ,TRAVEL hygiene ,MOBILE hospitals ,MEDICAL care costs ,HEALTH facilities - Abstract
This article discusses the knowledge, attitudes, and practices of US international travelers regarding the use of mobile travel health apps. The study collected data from 261 participants through an electronic survey, which assessed their smartphone usage habits, internet accessibility while traveling, concerns about personal health, and preferences for features in a travel health app. The majority of participants reported always carrying a smartphone during international travel and expressed interest in receiving health information through a travel health app. Preferred features for the app included real-time alerts about local outbreaks, information about nearby medical facilities, and COVID-19 travel-related restrictions. However, some participants had concerns about data security and privacy. The study provides insights into travelers' perspectives on mobile health apps and supports further development in this area. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. Universal Masking in Health Care Settings.
- Author
-
Brown, Tyler S., Mohareb, Amir M., and LaRocque, Regina C.
- Subjects
UNIVERSAL healthcare ,POOR communities ,SOCIAL marginality ,VACCINATION coverage ,INFECTION control - Abstract
This article discusses the ongoing debate surrounding universal masking in healthcare settings. While some argue for the elimination of universal masking, the authors express concern about the potential negative consequences, particularly for socially disadvantaged communities. These communities have already experienced disparities throughout the pandemic, including higher infection rates, lower vaccination coverage, and limited access to testing and treatments. The authors disagree with the viewpoint that eliminates universal masking, as they believe it will further concentrate the risk and burden of COVID-19 among the most disadvantaged, potentially damaging public trust in the healthcare system. They emphasize the importance of including diverse voices in health policy decisions and involving both infection control professionals and community members in discussions about mask requirements. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
7. Influenza: seasonality and travel-related considerations.
- Author
-
Kakoullis, Loukas, Steffen, Robert, Osterhaus, Albert, Goeijenbier, Marco, Rao, Sowmya R, Koiso, Satoshi, Hyle, Emily P, Ryan, Edward T, LaRocque, Regina C, and Chen, Lin H
- Subjects
MEDICAL personnel ,INFLUENZA ,FLU vaccine efficacy ,SEASONAL influenza ,SEASONAL variations of diseases ,VACCINATION - Abstract
Rationale for review This review aims to summarize the transmission patterns of influenza, its seasonality in different parts of the globe, air travel- and cruise ship-related influenza infections and interventions to reduce transmission. Key findings The seasonality of influenza varies globally, with peak periods occurring mainly between October and April in the northern hemisphere (NH) and between April and October in the southern hemisphere (SH) in temperate climate zones. However, influenza seasonality is significantly more variable in the tropics. Influenza is one of the most common travel-related, vaccine-preventable diseases and can be contracted during travel, such as during a cruise or through air travel. Additionally, travellers can come into contact with people from regions with ongoing influenza transmission. Current influenza immunization schedules in the NH and SH leave individuals susceptible during their respective spring and summer months if they travel to the other hemisphere during that time. Conclusions/recommendations The differences in influenza seasonality between hemispheres have substantial implications for the effectiveness of influenza vaccination of travellers. Health care providers should be aware of influenza activity when patients report travel plans, and they should provide alerts and advise on prevention, diagnostic and treatment options. To mitigate the risk of travel-related influenza, interventions include antivirals for self-treatment (in combination with the use of rapid self-tests), extending the shelf life of influenza vaccines to enable immunization during the summer months for international travellers and allowing access to the influenza vaccine used in the opposite hemisphere as a travel-related vaccine. With the currently available vaccines, the most important preventive measure involves optimizing the seasonal influenza vaccination. It is also imperative that influenza is recognized as a travel-related illness among both travellers and health care professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
- Author
-
Turbett, Sarah E, Tomkins-Tinch, Christopher H, Anahtar, Melis N, Dugdale, Caitlin M, Hyle, Emily P, Shenoy, Erica S, Shaw, Bennett, Egbuonu, Kenechukwu, Bowman, Kathryn A, Zachary, Kimon C, Adams, Gordon C, Hooper, David C, Ryan, Edward T, LaRocque, Regina C, Bassett, Ingrid V, Triant, Virginia A, Siddle, Katherine J, Rosenberg, Eric, Sabeti, Pardis C, and Schaffner, Stephen F
- Subjects
SARS-CoV-2 ,COVID-19 ,ACADEMIC medical centers ,REINFECTION ,RNA ,RETROSPECTIVE studies ,ACQUISITION of data ,RISK assessment ,GENOMES ,MEDICAL records ,DESCRIPTIVE statistics ,GENETIC techniques ,LONGITUDINAL method ,NUCLEIC acid amplification techniques - Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection is poorly understood, partly because few studies have systematically applied genomic analysis to distinguish reinfection from persistent RNA detection related to initial infection. We aimed to evaluate the characteristics of SARS-CoV-2 reinfection and persistent RNA detection using independent genomic, clinical, and laboratory assessments. Methods All individuals at a large academic medical center who underwent a SARS-CoV-2 nucleic acid amplification test (NAAT) ≥45 days after an initial positive test, with both tests between 14 March and 30 December 2020, were analyzed for potential reinfection. Inclusion criteria required having ≥2 positive NAATs collected ≥45 days apart with a cycle threshold (Ct) value <35 at repeat testing. For each included subject, likelihood of reinfection was assessed by viral genomic analysis of all available specimens with a Ct value <35, structured Ct trajectory criteria, and case-by-case review by infectious diseases physicians. Results Among 1569 individuals with repeat SARS-CoV-2 testing ≥45 days after an initial positive NAAT, 65 (4%) met cohort inclusion criteria. Viral genomic analysis characterized mutations present and was successful for 14/65 (22%) subjects. Six subjects had genomically supported reinfection, and 8 subjects had genomically supported persistent RNA detection. Compared to viral genomic analysis, clinical and laboratory assessments correctly distinguished reinfection from persistent RNA detection in 12/14 (86%) subjects but missed 2/6 (33%) genomically supported reinfections. Conclusions Despite good overall concordance with viral genomic analysis, clinical and Ct value-based assessments failed to identify 33% of genomically supported reinfections. Scaling-up genomic analysis for clinical use would improve detection of SARS-CoV-2 reinfections. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Climate Change and the Epidemiology of Infectious Diseases in the United States.
- Author
-
Edelson, Paul J, Harold, Rachel, Ackelsberg, Joel, Duchin, Jeffrey S, Lawrence, Steven J, Manabe, Yukari C, Zahn, Matt, and LaRocque, Regina C
- Subjects
COMMUNICABLE disease epidemiology ,COCCIDIOIDOMYCOSIS ,FOSSIL fuels ,AQUATIC microbiology ,INFECTIOUS disease transmission ,DISEASE prevalence ,VECTOR-borne diseases ,DRUG resistance in microorganisms ,CLIMATE change - Abstract
The earth is rapidly warming, driven by increasing atmospheric carbon dioxide and other gases that result primarily from fossil fuel combustion. In addition to causing arctic ice melting and extreme weather events, climatologic factors are linked strongly to the transmission of many infectious diseases. Changes in the prevalence of infectious diseases not only reflect the impacts of temperature, humidity, and other weather-related phenomena on pathogens, vectors, and animal hosts but are also part of a complex of social and environmental factors that will be affected by climate change, including land use, migration, and vector control. Vector- and waterborne diseases and coccidioidomycosis are all likely to be affected by a warming planet; there is also potential for climate-driven impacts on emerging infectious diseases and antimicrobial resistance. Additional resources for surveillance and public health activities are urgently needed, as well as systematic education of clinicians on the health impacts of climate change. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Comparison of long- and short-read metagenomic assembly for low-abundance species and resistance genes.
- Author
-
Yorki, Sosie, Shea, Terrance, Cuomo, Christina A, Walker, Bruce J, LaRocque, Regina C, Manson, Abigail L, Earl, Ashlee M, and Worby, Colin J
- Subjects
METAGENOMICS ,ESCHERICHIA coli ,GENES ,SPECIES ,DRUG resistance in bacteria ,MICROBIAL communities - Abstract
Recent technological and computational advances have made metagenomic assembly a viable approach to achieving high-resolution views of complex microbial communities. In previous benchmarking, short-read (SR) metagenomic assemblers had the highest accuracy, long-read (LR) assemblers generated the most contiguous sequences and hybrid (HY) assemblers balanced length and accuracy. However, no assessments have specifically compared the performance of these assemblers on low-abundance species, which include clinically relevant organisms in the gut. We generated semi-synthetic LR and SR datasets by spiking small and increasing amounts of Escherichia coli isolate reads into fecal metagenomes and, using different assemblers, examined E. coli contigs and the presence of antibiotic resistance genes (ARGs). For ARG assembly, although SR assemblers recovered more ARGs with high accuracy, even at low coverages, LR assemblies allowed for the placement of ARGs within longer, E. coli -specific contigs, thus pinpointing their taxonomic origin. HY assemblies identified resistance genes with high accuracy and had lower contiguity than LR assemblies. Each assembler type's strengths were maintained even when our isolate was spiked in with a competing strain, which fragmented and reduced the accuracy of all assemblies. For strain characterization and determining gene context, LR assembly is optimal, while for base-accurate gene identification, SR assemblers outperform other options. HY assembly offers contiguity and base accuracy, but requires generating data on multiple platforms, and may suffer high misassembly rates when strain diversity exists. Our results highlight the trade-offs associated with each approach for recovering low-abundance taxa, and that the optimal approach is goal-dependent. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions.
- Author
-
Posen, H Joshua, Wong, Waison, Farrar, Daniel S, Campigotto, Aaron, Chan, Tiffany, Barker, Kevin R, Hagmann, Stefan H F, Ryan, Edward T, LaRocque, Regina C, Earl, Ashlee M, Worby, Colin J, Castelli, Francesco, Fumadó, Victoria Pérez, Britton, Philip N, Libman, Michael, Hamer, Davidson H, and Morris, Shaun K
- Subjects
TYPHOID fever ,SALMONELLA enterica serovar Typhi ,WHOLE genome sequencing ,SALMONELLA typhi - Abstract
Background Extensively drug-resistant (XDR) typhoid fever is a threat to travelers to Pakistan. We describe a multicontinental case series of travel-acquired XDR typhoid fever to demonstrate the global spread of the problem and encourage preventive interventions as well as appropriate empiric antimicrobial use. Methods Cases were extracted from the GeoSentinel database, microbiologic laboratory records of two large hospitals in Toronto, Canada, and by invitation to TropNet sites. All isolates were confirmed XDR Salmonella enterica serovar Typhi (Salmonella typhi), with resistance to ampicillin, ceftriaxone, ciprofloxacin and trimethoprim–sulfamethoxazole. Results Seventeen cases were identified in Canada (10), USA (2), Spain (2), Italy (1), Australia (1) and Norway (1). Patients under 18 years represented 71% (12/17) of cases, and all patients travelled to Pakistan to visit friends or relatives. Only one patient is known to have been vaccinated. Predominant symptoms were fever, abdominal pain, vomiting and diarrhoea. Antimicrobial therapy was started on Day 1 of presentation in 75% (12/16) of patients, and transition to a carbapenem or azithromycin occurred a median of 2 days after blood culture was drawn. Antimicrobial susceptibilities were consistent with the XDR S. typhi phenotype, and whole genome sequencing on three isolates confirmed their belonging to the XDR variant of the H58 clade. Conclusions XDR typhoid fever is a particular risk for travelers to Pakistan, and empiric use of a carbapenem or azithromycin should be considered. Pre-travel typhoid vaccination and counseling are necessary and urgent interventions, especially for visiting friends and relatives travelers. Ongoing sentinel surveillance of XDR typhoid fever is needed to understand changing epidemiology. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
- Author
-
Chowdhury, Fahima, Akter, Afroza, Rahman, Taufiqur, Bhuiyan, Biswas, Rajib, Firoj, Md. Golam, Tauheed, Imam, Harris, Jason B., Larocque, Regina C., Ross, Allen G., McMillan, Nigel A. J., Charles, Richelle C., Ryan, Edward T., Calderwood, Stephen B., and Qadri, Firdausi
- Subjects
CHOLERA ,IMMUNE response ,ANTIBODY formation ,CHOLERA toxin ,PARASITIC diseases ,EPITHELIAL cells - Abstract
Background: Immune responses that target sialidase occur following natural cholera and have been associated with protection against cholera. Sialidase is a neuraminidase that facilitates the binding of cholera toxin (CT) to intestinal epithelial cells. Despite this, little is known about age-related sialidase-specific immune responses and the impact of nutritional status and co-infection on sialidase-specific immunity. Methods: We enrolled 50 culture-confirmed Vibrio cholerae O1 cholera cases presenting to the icddr,b Dhaka hospital with moderate to severe dehydration. We evaluated antibody responses out to 18 months (day 540) following cholera. We assessed immune responses targeting sialidase, lipopolysaccharide (LPS), cholera toxin B subunit (CtxB), and vibriocidal responses. We also explored the association of sialidase-specific immune responses to nutritional parameters and parasitic co-infection of cases. Results: This longitudinal cohort study showed age-dependent differences in anti-sialidase immune response after natural cholera infection. Adult patients developed plasma anti-sialidase IgA and IgG responses after acute infection (P<0.05), which gradually decreased from day 30 on. In children, no significant anti-sialidase IgA, IgM, and IgG response was seen with the exception of a late IgG response at study day 540 (p=0.05 compared to adults). There was a correlation between anti-sialidase IgA with vibriocidal titers, as well as anti-sialidase IgA and IgG with anti-LPS and anti-CtxB antibody responses in adult patients, whereas in children, a significant positive correlation was seen only between anti-sialidase IgA and CtxB IgA responses. Stunted children showed significantly lower anti-sialidase IgA, IgG, and IgM antibody responses and higher LPS IgG and IgM antibody responses than healthy children. The antisialidase IgA and IgG responses were significantly higher in cases with concomitant parasitic infection. Conclusion: Our data suggest that cholera patients develop age-distinct systemic and mucosal immune responses against sialidase. The stunted children have a lower anti-sialidase antibody response which may be associated with gut enteropathy and the neuraminidase plays an important role in augmented immune response in cholera patients infected with parasites. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.
- Author
-
Gregory, David J., Vannier, Augustin, Duey, Akiro H., Roady, Tyler J., Dzeng, Richard K., Pavlovic, Maia N., Chapin, Michael H., Mukherjee, Sonia, Wilmot, Hannah, Chronos, Nic, Charles, Richelle C., Ryan, Edward T., LaRocque, Regina C., Miller, Tyler E., Garcia-Beltran, Wilfredo F., Thierauf, Julia C., Iafrate, A. John, Mullenbrock, Steven, Stump, Mark D., and Wetzel, Randall K.
- Published
- 2022
- Full Text
- View/download PDF
14. High-risk US International Travelers Seeking Pretravel Consultation During the COVID-19 Pandemic.
- Author
-
Hyle, Emily P, Le, Mylinh H, Rao, Sowmya R, Mulroy, Nora M, Walker, Allison T, Ryan, Edward T, and LaRocque, Regina C
- Subjects
COVID-19 pandemic ,COVID-19 ,JAPANESE B encephalitis ,POSTVACCINAL encephalitis ,YELLOW fever - Abstract
Background To assess the implications of coronavirus disease 2019 (COVID-19)–related travel disruptions, we compared demographics and travel-related circumstances of US travelers seeking pretravel consultation regarding international travel at US Global TravEpiNet (GTEN) sites before and after the initiation of COVID-19 travel warnings. Methods We analyzed data in the GTEN database regarding traveler demographics and travel-related circumstances with standard questionnaires in the pre-COVID-19 period (January–December 2019) and the COVID-19 period (April 2020–March 2021), excluding travelers from January to March 2020. We conducted descriptive analyses of differences in demographics, travel-related circumstances, routine and travel-related vaccinations, and medications. Results Compared with 16 903 consultations in the pre-COVID-19 period, only 1564 consultations were recorded at GTEN sites during the COVID-19 period (90% reduction), with a greater proportion of travelers visiting friends and relatives (501/1564 [32%] vs 1525/16 903 [9%]), individuals traveling for >28 days (824/1564 [53%] vs 2522/16 903 [15%]), young children (6 mo–<6 y: 168/1564 [11%] vs 500/16 903 [3%]), and individuals traveling to Africa (1084/1564 [69%] vs 8049/16 903 [48%]). A smaller percentage of vaccine-eligible travelers received vaccines at pretravel consultations during the COVID-19 period than before, except for yellow fever and Japanese encephalitis vaccinations. Conclusions Compared with the pre-COVID-19 period, a greater proportion of travelers during the COVID - 19 period were young children, were planning to visit friends and relatives, were traveling for >28 days, or were traveling to Africa, which are circumstances that contribute to high risk for travel-related infections. Fewer vaccine-eligible travelers were administered travel-related vaccines at pretravel consultations. Counseling and vaccination focused on high-risk international travelers must be prioritized during the COVID-19 pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Infectious Diseases in a Changing Climate.
- Author
-
Phillips, Matthew C., LaRocque, Regina C., and Thompson III, George R.
- Subjects
MEDICAL climatology ,CLIMATE change & health ,COMMUNICABLE diseases ,CLIMATE change ,INFECTIOUS disease transmission - Abstract
This JAMA Insights in the Climate Change and Health series discusses the importance of clinicians having awareness of changes in the geographic range, seasonality, and intensity of transmission of infectious diseases to help them diagnose, treat, and prevent these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.
- Author
-
Schroeder, Philip H., Brenner, Laura N., Kaur, Varinderpal, Cromer, Sara J., Armstrong, Katrina, LaRocque, Regina C., Ryan, Edward T., Meigs, James B., Florez, Jose C., Charles, Richelle C., Mercader, Josep M., and Leong, Aaron
- Subjects
COVID-19 ,COVID-19 pandemic ,PREDICTION models ,PROTEOMICS ,BIOMARKERS - Abstract
Background: The high heterogeneity in the symptoms and severity of COVID-19 makes it challenging to identify high-risk patients early in the disease. Cardiometabolic comorbidities have shown strong associations with COVID-19 severity in epidemiologic studies. Cardiometabolic protein biomarkers, therefore, may provide predictive insight regarding which patients are most susceptible to severe illness from COVID-19. Methods: In plasma samples collected from 343 patients hospitalized with COVID-19 during the first wave of the pandemic, we measured 92 circulating protein biomarkers previously implicated in cardiometabolic disease. We performed proteomic analysis and developed predictive models for severe outcomes. We then used these models to predict the outcomes of out-of-sample patients hospitalized with COVID-19 later in the surge (N = 194). Results: We identified a set of seven protein biomarkers predictive of admission to the intensive care unit and/or death (ICU/death) within 28 days of presentation to care. Two of the biomarkers, ADAMTS13 and VEGFD, were associated with a lower risk of ICU/death. The remaining biomarkers, ACE2, IL-1RA, IL6, KIM1, and CTSL1, were associated with higher risk. When used to predict the outcomes of the future, out-of-sample patients, the predictive models built with these protein biomarkers outperformed all models built from standard clinical data, including known COVID-19 risk factors. Conclusions: These findings suggest that proteomic profiling can inform the early clinical impression of a patient's likelihood of developing severe COVID-19 outcomes and, ultimately, accelerate the recognition and treatment of high-risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad.
- Author
-
Bangs, Audrey C, Gastañaduy, Paul, Neilan, Anne M, Fiebelkorn, Amy Parker, Walker, Allison Taylor, Rao, Sowmya R, Ryan, Edward T, LaRocque, Regina C, Walensky, Rochelle P, and Hyle, Emily P
- Subjects
MEASLES prevention ,AIR travel ,COMPARATIVE studies ,TREATMENT effectiveness ,DESCRIPTIVE statistics ,COST effectiveness ,MMR vaccines ,SENSITIVITY & specificity (Statistics) ,TRAVEL hygiene ,CHILDREN - Abstract
Background Pediatric international travelers account for nearly half of measles importations in the United States. Over one third of pediatric international travelers depart the United States without the recommended measles-mumps-rubella (MMR) vaccinations: 2 doses for travelers ≥12 months and 1 dose for travelers 6 to <12 months. Methods We developed a model to compare 2 strategies among a simulated cohort of international travelers (6 months to <6 years): (1) No pretravel health encounter (PHE): travelers depart with baseline MMR vaccination status; (2) PHE: MMR-eligible travelers are offered vaccination. All pediatric travelers experience a destination-specific risk of measles exposure (mean, 30 exposures/million travelers). If exposed to measles, travelers' age and MMR vaccination status determine the risk of infection (range, 3%-90%). We included costs of medical care, contact tracing, and lost wages from the societal perspective. We varied inputs in sensitivity analyses. Model outcomes included projected measles cases, costs, and incremental cost-effectiveness ratios ($/quality-adjusted life year [QALY], cost-effectiveness threshold ≤$100 000/QALY). Results Compared with no PHE, PHE would avert 57 measles cases at $9.2 million/QALY among infant travelers and 7 measles cases at $15.0 million/QALY among preschool-aged travelers. Clinical benefits of PHE would be greatest for infants but cost-effective only for travelers to destinations with higher risk for measles exposure (ie, ≥160 exposures/million travelers) or if more US-acquired cases resulted from an infected traveler, such as in communities with limited MMR coverage. Conclusions Pretravel MMR vaccination provides the greatest clinical benefit for infant travelers and can be cost-effective before travel to destinations with high risk for measles exposure or from communities with low MMR vaccination coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Impact of a human gut microbe on Vibrio cholerae host colonization through biofilm enhancement.
- Author
-
Barrasso, Kelsey, Chac, Denise, Debela, Meti D., Geigel, Catherine, Steenhaut, Anjali, Seda, Abigail Rivera, Dunmire, Chelsea N., Harris, Jason B., Larocque, Regina C., Midani, Firas S., Qadri, Firdausi, Jing Yan, Weil, Ana A., and Wai-Leung Ng
- Published
- 2022
- Full Text
- View/download PDF
19. Systemic, Mucosal, and Memory Immune Responses following Cholera.
- Author
-
Ryan, Edward T., Leung, Daniel T., Jensen, Owen, Weil, Ana A., Bhuiyan, Taufiqur Rahman, Khan, Ashraful Islam, Chowdhury, Fahima, LaRocque, Regina C., Harris, Jason B., Calderwood, Stephen B., Qadri, Firdausi, and Charles, Richelle C.
- Published
- 2021
- Full Text
- View/download PDF
20. Antimicrobial-resistant bacteria in international travelers.
- Author
-
Sridhar, Sushmita, Turbett, Sarah E., Harris, Jason B., and LaRocque, Regina C.
- Published
- 2021
- Full Text
- View/download PDF
21. A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients.
- Author
-
Levade, Inès, Khan, Ashraful I., Chowdhury, Fahima, Calderwood, Stephen B., Ryan, Edward T., Harris, Jason B., LaRocque, Regina C., Bhuiyan, Taufiqur R., Qadri, Firdausi, Weil, Ana A., and Shapiro, B. Jesse
- Published
- 2021
- Full Text
- View/download PDF
22. An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh.
- Author
-
Uddin, Muhammad Ikhtear, Hossain, Motaher, Islam, Shahidul, Akter, Aklima, Nishat, Naoshin Sharmin, Nila, Tasnin Akter, Rafique, Tanzeem Ahmed, Leung, Daniel T., Calderwood, Stephen B., Ryan, Edward T., Harris, Jason B., LaRocque, Regina C., Bhuiyan, Taufiqur Rahman, and Qadri, Firdausi
- Subjects
INTESTINAL infections ,MALNUTRITION ,ENZYME-linked immunosorbent assay ,INTESTINAL diseases ,PARASITIC diseases ,BIOMARKERS - Abstract
Interventional studies targeting environment enteropathy (EE) are impeded by the lack of appropriate, validated, non-invasive biomarkers of EE. Thus, we aimed to validate the association of potential biomarkers for EE with enteric infections and nutritional status in a longitudinal birth cohort study. We measured endotoxin core antibody (EndoCab) and soluble CD14 (sCD14) in serum, and myeloperoxidase (MPO) in feces using commercially available enzyme-linked immunosorbent assay (ELISA) kits. We found that levels of serum EndoCab and sCD14 increase with the cumulative incidence of enteric infections. We observed a significant correlation between the fecal MPO level in the children at 24 months of age with the total number of bacterial and viral infections, the total number of parasitic infections, and the total number of diarrheal episodes and diarrheal duration. We observed that the levels of serum EndoCab, sCD14, and fecal MPO at 3 months of age were significantly associated with whether children were malnourished at 18 months of age or not. Biomarkers such as fecal MPO, serum EndoCab and sCD14 in children at an early age may be useful as a measure of cumulative burden of preceding enteric infections, which are predictive of subsequent malnutrition status and may be useful non-invasive biomarkers for EE. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Predicting Vibrio cholerae Infection and Disease Severity Using Metagenomics in a Prospective Cohort Study.
- Author
-
Levade, Inès, Saber, Morteza M, Midani, Firas S, Chowdhury, Fahima, Khan, Ashraful I, Begum, Yasmin A, Ryan, Edward T, David, Lawrence A, Calderwood, Stephen B, Harris, Jason B, LaRocque, Regina C, Qadri, Firdausi, Shapiro, B Jesse, Weil, Ana A, and Midani, Firas
- Subjects
VIBRIO infections ,CHOLERA ,VIBRIO cholerae ,METAGENOMICS ,SHOTGUN sequencing ,LONGITUDINAL method ,GENE families ,CHOLERA diagnosis ,RESEARCH ,BIOLOGICAL evolution ,GRAM-negative bacteria ,RESEARCH methodology ,PROGNOSIS ,MEDICAL cooperation ,EVALUATION research ,SEVERITY of illness index ,COMPARATIVE studies ,GENOMES ,DISEASE susceptibility ,RESEARCH funding ,RECEIVER operating characteristic curves - Abstract
Background: Susceptibility to Vibrio cholerae infection is affected by blood group, age, and preexisting immunity, but these factors only partially explain who becomes infected. A recent study used 16S ribosomal RNA amplicon sequencing to quantify the composition of the gut microbiome and identify predictive biomarkers of infection with limited taxonomic resolution.Methods: To achieve increased resolution of gut microbial factors associated with V. cholerae susceptibility and identify predictors of symptomatic disease, we applied deep shotgun metagenomic sequencing to a cohort of household contacts of patients with cholera.Results: Using machine learning, we resolved species, strains, gene families, and cellular pathways in the microbiome at the time of exposure to V. cholerae to identify markers that predict infection and symptoms. Use of metagenomic features improved the precision and accuracy of prediction relative to 16S sequencing. We also predicted disease severity, although with greater uncertainty than our infection prediction. Species within the genera Prevotella and Bifidobacterium predicted protection from infection, and genes involved in iron metabolism were also correlated with protection.Conclusion: Our results highlight the power of metagenomics to predict disease outcomes and suggest specific species and genes for experimental testing to investigate mechanisms of microbiome-related protection from cholera. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
24. Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International Travelers.
- Author
-
Worby, Colin J, Earl, Ashlee M, Turbett, Sarah E, Becker, Margaret, Rao, Sowmya R, Oliver, Elizabeth, Walker, Allison Taylor, Walters, Maroya, Kelly, Paul, Leung, Daniel T, Knouse, Mark, Hagmann, Stefan H F, Ryan, Edward T, and LaRocque, Regina C
- Subjects
TRAVEL hygiene ,TRAVELERS ,DRUG resistance in bacteria ,DIARRHEA - Abstract
We performed prospective screening of stool for multidrug-resistant organisms from 608 US international travelers and identified an acquisition rate of 38% following travel. Carriage rates remained significantly elevated for at least 6 months post-travel. Travel-related diarrhea was a risk factor for acquisition, as well as for long-term carriage upon return. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers' Diarrhea in Global TravEpiNet, 2009–2018.
- Author
-
Gandhi, Aditya R, Rao, Sowmya R, Chen, Lin H, Nelson, Michael D, Ryan, Edward T, LaRocque, Regina C, and Hyle, Emily P
- Subjects
ANTIBIOTICS ,AZITHROMYCIN ,DIARRHEA ,TIME series analysis ,TRAVELERS - Abstract
Background International travelers are often prescribed antibiotics for self-treatment of travelers' diarrhea (TD), but the benefits and risks of antibiotics are debated. We assessed the prescribing patterns of empiric antibiotics for TD in international travelers evaluated at Global TravEpiNet (GTEN) sites (2009–2018). Methods We performed a prospective, multisite cross-sectional study regarding antibiotic prescriptions for the self-treatment of TD at 31 GTEN sites providing pretravel consultations to adult international travelers. We described traveler demographics, itineraries, and antibiotic(s) prescribed. We used multivariable logistic regressions to assess the association of year of consultation with antibiotic prescribing (yes/no) and class (fluoroquinolones vs azithromycin). We performed interrupted time-series analyses to examine differences in prescribing before and after the Food and Drug Administration (FDA) warning on fluoroquinolones (July 2016). Results Antibiotics were not prescribed in 23 096 (22.2%) of 103 843 eligible pretravel GTEN consultations; azithromycin and fluoroquinolones were most frequently prescribed. Antibiotic prescribing declined significantly each year between 2009 and 2018 (odds ratio [OR], 0.84; 95% CI, 0.79–0.89), as did fluoroquinolone prescribing, relative to azithromycin (OR, 0.77; 95% CI, 0.73–0.82). The rate of decline in fluoroquinolone prescribing was significantly greater after the FDA fluoroquinolone warning (15.3%/year) than before (1.1%/year; P <.001). Conclusions Empiric antibiotics for TD were prescribed in >75% of pretravel GTEN consultations, but antibiotic prescribing declined steadily between 2009 and 2018. Fluoroquinolones were less frequently prescribed than azithromycin, especially after the 2016 FDA fluoroquinolone warning. Emphasis on the risks of antibiotics may influence antibiotic prescribing by providers for empiric treatment of TD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. Mitigating the Twin Threats of Climate-Driven Atlantic Hurricanes and COVID-19 Transmission.
- Author
-
Shultz, James M., Kossin, James P., Hertelendy, Attila, Burkle, Fredrick, Fugate, Craig, Sherman, Ronald, Bakalar, Johnna, Berg, Kim, Maggioni, Alessandra, Espinel, Zelde, Sands, Duane E., LaRocque, Regina C., Salas, Renee N., and Galea, Sandro
- Subjects
COVID-19 ,MEDICAL personnel ,SCIENTIFIC knowledge ,PERSONAL protective equipment ,HURRICANES - Abstract
The co-occurrence of the 2020 Atlantic hurricane season and the ongoing coronavirus disease 2019 (COVID-19) pandemic creates complex dilemmas for protecting populations from these intersecting threats. Climate change is likely contributing to stronger, wetter, slower-moving, and more dangerous hurricanes. Climate-driven hazards underscore the imperative for timely warning, evacuation, and sheltering of storm-threatened populations – proven life-saving protective measures that gather evacuees together inside durable, enclosed spaces when a hurricane approaches. Meanwhile, the rapid acquisition of scientific knowledge regarding how COVID-19 spreads has guided mass anti-contagion strategies, including lockdowns, sheltering at home, physical distancing, donning personal protective equipment, conscientious handwashing, and hygiene practices. These life-saving strategies, credited with preventing millions of COVID-19 cases, separate and move people apart. Enforcement coupled with fear of contracting COVID-19 have motivated high levels of adherence to these stringent regulations. How will populations react when warned to shelter from an oncoming Atlantic hurricane while COVID-19 is actively circulating in the community? Emergency managers, health care providers, and public health preparedness professionals must create viable solutions to confront these potential scenarios: elevated rates of hurricane-related injury and mortality among persons who refuse to evacuate due to fear of COVID-19, and the resurgence of COVID-19 cases among hurricane evacuees who shelter together. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
27. Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States.
- Author
-
Hyle, Emily P, Fields, Naomi F, Fiebelkorn, Amy Parker, Walker, Allison Taylor, Gastañaduy, Paul, Rao, Sowmya R, Ryan, Edward T, LaRocque, Regina C, and Walensky, Rochelle P
- Subjects
PREVENTION of communicable diseases ,MEASLES prevention ,MMR vaccines ,MEDICAL care costs ,VACCINATION ,COST effectiveness ,DECISION trees ,ECONOMIC aspects of diseases ,EPIDEMICS ,MEASLES ,RISK assessment ,TRAVEL hygiene ,VACCINES ,DISEASE risk factors - Abstract
Background Measles importations and the subsequent spread from US travelers returning from abroad are responsible for most measles cases in the United States. Increasing measles-mumps-rubella (MMR) vaccination among departing US travelers could reduce the clinical impact and costs of measles in the United States. Methods We designed a decision tree to evaluate MMR vaccination at a pretravel health encounter (PHE), compared with no encounter. We derived input parameters from Global TravEpiNet data and literature. We quantified Risk
exposure to measles while traveling and the average number of US-acquired cases and contacts due to a measles importation. In sensitivity analyses, we examined the impact of destination-specific Riskexposure , including hot spots with active measles outbreaks; the percentage of previously-unvaccinated travelers; and the percentage of travelers returning to US communities with heterogeneous MMR coverage. Results The no-encounter strategy projected 22 imported and 66 US-acquired measles cases, costing $14.8M per 10M travelers. The PHE strategy projected 15 imported and 35 US-acquired cases at $190.3M per 10M travelers. PHE was not cost effective for all international travelers (incremental cost-effectiveness ratio [ICER] $4.6M/measles case averted), but offered better value (ICER <$100 000/measles case averted) or was even cost saving for travelers to hot spots, especially if travelers were previously unvaccinated or returning to US communities with heterogeneous MMR coverage. Conclusions PHEs that improve MMR vaccination among US international travelers could reduce measles cases, but are costly. The best value is for travelers with a high likelihood of measles exposure, especially if the travelers are previously unvaccinated or will return to US communities with heterogeneous MMR coverage. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
28. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.
- Author
-
Midani, Firas S, Weil, Ana A, Chowdhury, Fahima, Begum, Yasmin A, Khan, Ashraful I, Debela, Meti D, Durand, Heather K, Reese, Aspen T, Nimmagadda, Sai N, Silverman, Justin D, Ellis, Crystal N, Ryan, Edward T, Calderwood, Stephen B, Harris, Jason B, Qadri, Firdausi, David, Lawrence A, and LaRocque, Regina C
- Subjects
PATHOGENIC microorganisms ,COMMUNICABLE diseases ,VIBRIO cholerae ,INFECTION ,MEDICAL microbiology ,MICROBIOLOGY - Abstract
Background: Cholera is a public health problem worldwide, and the risk factors for infection are only partially understood.Methods: We prospectively studied household contacts of patients with cholera to compare those who were infected to those who were not. We constructed predictive machine learning models of susceptibility, using baseline gut microbiota data. We identified bacterial taxa associated with susceptibility to Vibrio cholerae infection and tested these taxa for interactions with V. cholerae in vitro.Results: We found that machine learning models based on gut microbiota, as well as models based on known clinical and epidemiological risk factors, predicted V. cholerae infection. A predictive gut microbiota of roughly 100 bacterial taxa discriminated between contacts who developed infection and those who did not. Susceptibility to cholera was associated with depleted levels of microbes from the phylum Bacteroidetes. By contrast, a microbe associated with cholera by our modeling framework, Paracoccus aminovorans, promoted the in vitro growth of V. cholerae. Gut microbiota structure, clinical outcome, and age were also linked.Conclusion: These findings support the hypothesis that abnormal gut microbial communities are a host factor related to V. cholerae susceptibility. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
29. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
- Author
-
Aktar, Amena, Rahman, M. Arifur, Afrin, Sadia, Akter, Aklima, Uddin, Taher, Yasmin, Tahirah, Sami, Md. Israk Nur, Dash, Pinki, Jahan, Sultana Rownok, Chowdhury, Fahima, Khan, Ashraful I., LaRocque, Regina C., Charles, Richelle C., Bhuiyan, Taufiqur Rahman, Mandlik, Anjali, Kelly, Meagan, Kováč, Pavol, Xu, Peng, Calderwood, Stephen B., and Harris, Jason B.
- Subjects
VIBRIO cholerae ,CHOLERA ,POLYSACCHARIDES ,B cells ,IMMUNOGLOBULIN A ,IMMUNOGLOBULIN G ,PATIENTS - Abstract
Background: The mediators of protection against cholera, a severe dehydrating illness of humans caused by Vibrio cholerae, are unknown. We have previously shown that plasma IgA as well as memory B IgG cells targeting lipopolysaccharide (LPS) of Vibrio cholerae O1 correlate with protection against V. cholerae O1 infection among household contacts of cholera patients. Protection against cholera is serogroup specific, and serogroup specificity is defined by the O-specific polysaccharide (OSP) component of LPS. Therefore, we prospectively followed household contacts of cholera patients to determine whether OSP-specific immune responses present at the time of enrollment are associated with protection against V. cholerae infection. Methodology: In this study, we enrolled two hundred forty two household contacts of one hundred fifty index patients who were infected with Vibrio cholerae. We determined OSP-specific memory B cells and plasma IgA, IgG and IgM antibody responses on study entry (day 2). Principle findings: The presence of OSP-specific plasma IgA, IgM, and IgG antibody responses on study entry were associated with a decrease in the risk of infection in household contacts (IgA, p = 0.015; IgM, p = 0.01, and IgG, p = 0.024). In addition, the presence of OSP-specific IgG memory B cell responses in peripheral blood on study entry was also associated with a decreased risk of infection (44% reduction; 95% CI: 31.1 to 99.8) in contacts. No protection was associated with cholera toxin B subunit (CtxB)-specific memory B cell responses. Conclusion: These results suggest that immune responses that target OSP, both in plasma and memory responses, may be important in mediating protection against infection with V. cholerae O1. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
30. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
- Author
-
Islam, Kamrul, Hossain, Motaher, Kelly, Meagan, Mayo Smith, Leslie M., Charles, Richelle C., Bhuiyan, Taufiqur Rahman, Kováč, Pavol, Xu, Peng, LaRocque, Regina C., Calderwood, Stephen B., Simon, Jakub K., Chen, Wilbur H., Haney, Douglas, Lock, Michael, Lyon, Caroline E., Kirkpatrick, Beth D., Cohen, Mitchell, Levine, Myron M., Gurwith, Marc, and Harris, Jason B.
- Subjects
CHOLERA ,IMMUNE response ,IMMUNIZATION ,B cells ,CLINICAL trials - Abstract
Background: Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V. cholerae are involved in mediating protection against cholera. We therefore assessed whether antibody responses against OSP occur after vaccination with live attenuated oral cholera vaccine CVD 103-HgR, and whether such responses correlate with protection against cholera. Methodology: We assessed adult North American volunteers (n = 46) who were vaccinated with 5 × 10
8 colony-forming units (CFU) of oral cholera vaccine CVD 103-HgR and then orally challenged with approximately 1 × 105 CFU of wild-type V. cholerae O1 El Tor Inaba strain N16961, either 10 or 90 days post-vaccination. Principal findings: Vaccination was associated with induction of significant serum IgM and IgA anti-OSP and vibriocidal antibody responses within 10 days of vaccination. There was significant correlation between anti-OSP and vibriocidal antibody responses. IgM and IgA anti-OSP responses on day 10 following vaccination were associated with lower post-challenge stool volume (r = −0.44, P = 0.002; r = −0.36, P = 0.01; respectively), and none of 27 vaccinees who developed a ≥1.5 fold increase in any antibody isotype targeting OSP on day 10 following vaccination compared to baseline developed moderate or severe cholera following experimental challenge, while 5 of 19 who did not develop such anti-OSP responses did (P = 0.01). Conclusion: Oral vaccination with live attenuated cholera vaccine CVD 103-HgR induces antibodies that target V. cholerae OSP, and these anti-OSP responses correlate with protection against diarrhea following experimental challenge with V. cholerae O1. Trial registration: ClinicalTrials.gov [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
31. In the Clinic®. Travel Medicine.
- Author
-
Leung, Daniel T, LaRocque, Regina C, and Ryan, Edward T
- Subjects
PREVENTION of bites & stings ,DECOMPRESSION sickness ,MOUNTAIN sickness ,PREVENTION of sexually transmitted diseases ,TRAFFIC safety ,PREVENTION of injury ,ZOONOSES ,AIRPLANES ,ANIMALS ,INSECTS ,PRIMARY health care ,SHIPS ,TRAVEL hygiene ,FOOD safety ,PREVENTION - Published
- 2018
- Full Text
- View/download PDF
32. Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel.
- Author
-
Hagmann, Stefan H. F., Rao, Sowmya R., LaRocque, Regina C., Erskine, Stefanie, Jentes, Emily S., Walker, Allison T., Barnett, Elizabeth D., Chen, Lin H., Hamer, Davidson H., Ryan, Edward T., and Global TravEpiNet Consortium and the Boston Area Travel Medicine Network
- Published
- 2017
- Full Text
- View/download PDF
33. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.
- Author
-
Hyle, Emily P., Rao, Sowmya R., Jentes, Emily S., Fiebelkorn, Amy Parker, Hagmann, Stefan H. F., Walker, Allison Taylor, Walensky, Rochelle P., Ryan, Edward T., and LaRocque, Regina C.
- Subjects
VACCINATION ,MEASLES vaccines ,RUBELLA vaccines ,MUMPS vaccines ,PUBLIC health ,DECISION making in clinical medicine - Abstract
Background: Measles outbreaks continue to occur in the United States and are mostly due to infections in returning travelers. Objective: To describe how providers assessed the measles immunity status of departing U.S. adult travelers seeking pretravel consultation and to assess reasons given for nonvaccination among those considered eligible to receive the measles, mumps, rubella (MMR) vaccine. Design: Observational study in U.S. pretravel clinics. Setting: 24 sites associated with Global TravEpiNet (GTEN), a Centers for Disease Control and Prevention–funded consortium. Patients: Adults (born in or after 1957) attending pretravel consultations at GTEN sites (2009 to 2014). Measurements: Structured questionnaire completed by traveler and provider during pretravel consultation. Results: 40 810 adult travelers were included; providers considered 6612 (16%) to be eligible for MMR vaccine at the time of pretravel consultation. Of the MMR-eligible, 3477 (53%) were not vaccinated at the visit; of these, 1689 (48%) were not vaccinated because of traveler refusal, 966 (28%) because of provider decision, and 822 (24%) because of health systems barriers. Most MMR-eligible travelers who were not vaccinated were evaluated in the South (2262 travelers [65%]) or at nonacademic centers (1777 travelers [51%]). Nonvaccination due to traveler refusal was most frequent in the South (1432 travelers [63%]) and in nonacademic centers (1178 travelers [66%]). Limitation: These estimates could underrepresent the opportunities for MMR vaccination because providers accepted verbal histories of disease and vaccination as evidence of immunity. Conclusion: Of U.S. adult travelers who presented for pretravel consultation at GTEN sites, 16% met criteria for MMR vaccination according to the provider's assessment, but fewer than half of these travelers were vaccinated. An increase in MMR vaccination of eligible U.S. adult travelers could reduce the likelihood of importation and transmission of measles virus. Primary Funding Source: Centers for Disease Control and Prevention, National Institutes of Health, and the Steve and Deborah Gorlin MGH Research Scholars Award. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
34. Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical Medicine.
- Author
-
Tucker, Joseph D., Hughes, Molly A., Durvasula, Ravi V., Vinetz, Joseph M., McGovern, Victoria P., Schultz, Rhonda, Dunavan, Claire Panosian, Wilson, Mary E., Milner, Danny A., LaRocque, Regina C., Calderwood, Stephen B., Guerrant, Richard L., Weller, Peter F., and Taylor, Terrie E.
- Subjects
MEDICAL education ,POSTDOCTORAL programs ,GLOBALIZATION ,TROPICAL medicine ,RATE of return - Abstract
Background. In modern academic medicine, especially in the fields of infectious diseases and global health, aspiring physician- scientists often wait years before achieving independence as basic, translational, and clinical investigators. This study employed mixed methods to evaluate the success of the Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene (BWF/ASTMH) global health postdoctoral fellowship in promoting scientific independence. Methods. We examined quantitative data obtained from the National Institutes of Health (NIH) and qualitative data provided by the ASTMH and program participants to assess BWF/ASTMH trainees’ success in earning NIH grants, publishing manuscripts, and gaining faculty positions. We also calculated the return on investment (ROI) associated with the training program by dividing direct costs of NIH research grants awarded to trainees by the direct costs invested by the BWF/ASTMH fellowship. Results. Forty-one trainees received fellowships between 2001 and 2015. Within 3 years of completing their fellowships, 21 of 35 (60%) had received career development awards, and within 5 years, 12 of 26 (46%) had received independent research awards. Overall, 22 of 35 (63%) received 1 or more research awards. BWF/ASTMH recipients with at least 3 years of follow-up data had coauthored a mean of 36 publications (range, 2–151) and 29 of 35 (82%) held academic positions. The return on investment was 11.9 overall and 31.8 for fellowships awarded between 2001 and 2004. Conclusions. Between 2001 and 2015, the BWF/ASTMH postdoctoral training program successfully facilitated progress to scientific independence. This program model underscores the importance of custom-designed postdoctoral training as a bridge to NIH awards and professional autonomy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
35. Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016.
- Author
-
Lammert, Sara, Walker, Allison Taylor, Erskine, Stefanie, Rao, Sowmya R., Esposito, Douglas H., Ryan, Edward T., Robbins, Gregory K., and LaRocque, Regina C.
- Subjects
ZIKA virus ,ZIKA Virus Epidemic, 2015-2016 ,ZIKA virus infections ,MATERNAL health ,TRAVELERS ,DISEASE risk factors ,VIRAL transmission ,COMMUNICABLE disease epidemiology ,COMPARATIVE studies ,HISTORY ,RESEARCH methodology ,MEDICAL cooperation ,PREGNANCY complications ,RESEARCH ,RESEARCH funding ,SEASONS ,TRAVEL ,EVALUATION research - Abstract
Zika virus has recently been introduced to the Americas and is spreading rapidly. We evaluated the characteristics of US travelers to Zika virus-affected countries who were seen at Global TravEpiNet sites during March 2015-October 2016. Nearly three quarters of travelers were men or women of reproductive age. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
36. Pre-Travel Medical Preparation of Business and Occupational Travelers.
- Author
-
Khan, Nomana M., Jentes, Emily S., Brown, Clive, Han, Pauline, Rao, Sowmya R., Kozarsky, Phyllis, Hagmann, Stefan H. F., LaRocque, Regina C., and Ryan, Edward T.
- Published
- 2016
- Full Text
- View/download PDF
37. Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014.
- Author
-
Chowdhury, Fahima, Mather, Alison E., Begum, Yasmin Ara, Asaduzzaman, Muhammad, Baby, Nabilah, Sharmin, Salma, Biswas, Rajib, Ikhtear Uddin, Muhammad, LaRocque, Regina C., Harris, Jason B., Calderwood, Stephen B., Ryan, Edward T., Clemens, John D., Thomson, Nicholas R., and Qadri, Firdausi
- Subjects
CHOLERA ,VIBRIO infections ,MEDICAL care ,PANDEMICS - Abstract
Background: Cholera is endemic in Bangladesh, with outbreaks reported annually. Currently, the majority of epidemic cholera reported globally is El Tor biotype Vibrio cholerae isolates of the serogroup O1. However, in Bangladesh, outbreaks attributed to V. cholerae serogroup O139 isolates, which fall within the same phylogenetic lineage as the O1 serogroup isolates, were seen between 1992 and 1993 and in 2002 to 2005. Since then, V. cholerae serogroup O139 has only been sporadically isolated in Bangladesh and is now rarely isolated elsewhere. Methods: Here, we present case histories of four cholera patients infected with V. cholerae serogroup O139 in 2013 and 2014 in Bangladesh. We comprehensively typed these isolates using conventional approaches, as well as by whole genome sequencing. Phenotypic typing and PCR confirmed all four isolates belonging to the O139 serogroup. Findings: Whole genome sequencing revealed that three of the isolates were phylogenetically closely related to previously sequenced El Tor biotype, pandemic 7, toxigenic V. cholerae O139 isolates originating from Bangladesh and elsewhere. The fourth isolate was a non-toxigenic V. cholerae that, by conventional approaches, typed as O139 serogroup but was genetically divergent from previously sequenced pandemic 7 V. cholerae lineages belonging to the O139 or O1 serogroups. Conclusion: These results suggest that previously observed lineages of V. cholerae O139 persist in Bangladesh and can cause clinical disease and that a novel disease-causing non-toxigenic O139 isolate also occurs. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
38. Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection.
- Author
-
Ivers, Louise C., Charles, Richelle C., Hilaire, Isabelle J., Mayo-Smith, Leslie M., Teng, Jessica E., Jerome, J. Gregory, Rychert, Jenna, LaRocque, Regina C., Peng Xu, Kováč, Pavol, Ryan, Edward T., Qadri, Firdausi, Almazor, Charles P., Franke, Molly F., and Harris, Jason B.
- Subjects
CHOLERA vaccines ,HIV infections ,VIRAL vaccines ,DISEASES in adults ,SEROCONVERSION - Abstract
We evaluated immune responses following bivalent oral cholera vaccination (Shanchol [Shantha Biotechnics]; BivWC) in a cohort of 25 human immunodeficiency virus (HIV)-infected adults in Haiti. Compared with adults without HIV infection, vaccination in HIV-infected individuals resulted in lower vibriocidal responses against Vibrio cholerae O1, and there was a positive relationship between the CD4
+ T-cell count and vibriocidal responses following vaccination. Nevertheless, seroconversion occurred at a rate of 65% against the Ogawa serotype and 74% against the Inaba serotype in adults with HIV infection. These results suggest that the vaccine retains substantial immunogenicity in adults with HIV infection and may benefit this population by protecting against cholera. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
39. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
- Author
-
Sayeed, Md. Abu, Bufano, Meagan Kelly, Xu, Peng, Eckhoff, Grace, Charles, Richelle C., Alam, Mohammad Murshid, Sultana, Tania, Rashu, Md. Rasheduzzaman, Berger, Amanda, Gonzalez-Escobedo, Geoffrey, Mandlik, Anjali, Bhuiyan, Taufiqur Rahman, Leung, Daniel T., LaRocque, Regina C., Harris, Jason B., Calderwood, Stephen B., Qadri, Firdausi, Vann, W. F., Kováč, Pavol, and Ryan, Edward T.
- Subjects
VIBRIO cholerae ,CHOLERA ,POLYSACCHARIDES ,LIPOPOLYSACCHARIDES ,IMMUNIZATION ,IMMUNE response ,VACCINATION - Abstract
Background: Vibrio cholerae is the cause of cholera, a severe watery diarrhea. Protection against cholera is serogroup specific. Serogroup specificity is defined by the O-specific polysaccharide (OSP) component of lipopolysaccharide (LPS). Methodology: Here we describe a conjugate vaccine for cholera prepared via squaric acid chemistry from the OSP of V. cholerae O1 Inaba strain PIC018 and a recombinant heavy chain fragment of tetanus toxin (OSP:rTTHc). We assessed a range of vaccine doses based on the OSP content of the vaccine (10-50 μg), vaccine compositions varying by molar loading ratio of OSP to rTTHc (3:1, 5:1, 10:1), effect of an adjuvant, and route of immunization. Principle Findings: Immunized mice developed prominent anti-OSP and anti-TT serum IgG responses, as well as vibriocidal antibody and memory B cell responses following intramuscular or intradermal vaccination. Mice did not develop anti-squarate responses. Intestinal lamina proprial IgA responses targeting OSP occurred following intradermal vaccination. In general, we found comparable immune responses in mice immunized with these variations, although memory B cell and vibriocidal responses were blunted in mice receiving the highest dose of vaccine (50 μg). We found no appreciable change in immune responses when the conjugate vaccine was administered in the presence or absence of immunoadjuvant alum. Administration of OSP:rTTHc resulted in 55% protective efficacy in a mouse survival cholera challenge model. Conclusion: We report development of an Inaba OSP:rTTHc conjugate vaccine that induces memory responses and protection against cholera in mice. Development of an effective cholera conjugate vaccine that induces high level and long-term immune responses against OSP would be beneficial, especially in young children who respond poorly to polysaccharide antigens. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
40. Household Transmission of Vibrio cholerae in Bangladesh.
- Author
-
Sugimoto, Jonathan D., Koepke, Amanda A., Kenah, Eben E., Halloran, M. Elizabeth, Chowdhury, Fahima, Khan, Ashraful I., LaRocque, Regina C., Yang, Yang, Ryan, Edward T., Qadri, Firdausi, Calderwood, Stephen B., Harris, Jason B., and Longini Jr., Ira M.
- Subjects
CHOLERA ,VIBRIO cholerae ,WATERBORNE infection ,VIBRIO infections ,FECAL contamination ,FOOD contamination - Abstract
Background: Vibrio cholerae infections cluster in households. This study's objective was to quantify the relative contribution of direct, within-household exposure (for example, via contamination of household food, water, or surfaces) to endemic cholera transmission. Quantifying the relative contribution of direct exposure is important for planning effective prevention and control measures. Methodology/Principal Findings: Symptom histories and multiple blood and fecal specimens were prospectively collected from household members of hospital-ascertained cholera cases in Bangladesh from 2001–2006. We estimated the probabilities of cholera transmission through 1) direct exposure within the household and 2) contact with community-based sources of infection. The natural history of cholera infection and covariate effects on transmission were considered. Significant direct transmission (p-value<0.0001) occurred among 1414 members of 364 households. Fecal shedding of O1 El Tor Ogawa was associated with a 4.9% (95% confidence interval: 0.9%–22.8%) risk of infection among household contacts through direct exposure during an 11-day infectious period (mean length). The estimated 11-day risk of O1 El Tor Ogawa infection through exposure to community-based sources was 2.5% (0.8%–8.0%). The corresponding estimated risks for O1 El Tor Inaba and O139 infection were 3.7% (0.7%–16.6%) and 8.2% (2.1%–27.1%) through direct exposure, and 3.4% (1.7%–6.7%) and 2.0% (0.5%–7.3%) through community-based exposure. Children under 5 years-old were at elevated risk of infection. Limitations of the study may have led to an underestimation of the true risk of cholera infection. For instance, available covariate data may have incompletely characterized levels of pre-existing immunity to cholera infection. Transmission via direct exposure occurring outside of the household was not considered. Conclusions: Direct exposure contributes substantially to endemic transmission of symptomatic cholera in an urban setting. We provide the first estimate of the transmissibility of endemic cholera within prospectively-followed members of households. The role of direct transmission must be considered when planning cholera control activities. Author Summary: Since John Snow's ground-breaking investigations of the devastating outbreaks in 19
th -century London, cholera has been considered the quintessential waterborne human infection, transmitting via fecal contamination of environmental water sources. Recently, renewed interest has been paid to the potential importance of transmission through direct exposure within close-contact groups, such as, via fecal contamination of surfaces, food, or drinking water within households. Significant direct transmission of cholera within close contact groups would represent a new target for innovative prevention and control strategies. We estimated the probability of transmission 1) via direct contact within 364 urban households located in an endemic cholera setting (Dhaka, Bangladesh) and 2) via exposure to sources located outside of these households. In this setting we estimated a 4 to 8 percent probability of becoming infected with cholera via direct exposure within households in this setting versus a 2 to 3 percent likelihood of infection due to exposure to external sources over a comparable time period. Our results demonstrate that direct (within-household) transmission is a significant component of endemic cholera transmission, suggesting that biomedical and behavioral-modification interventions specifically targeting this mode of transmission could substantially reduce the cholera burden in this type of setting. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
41. Household Transmission of Vibrio cholerae in Bangladesh.
- Author
-
Sugimoto, Jonathan D., Koepke, Amanda A., Kenah, Eben E., Halloran, M. Elizabeth, Chowdhury, Fahima, Khan, Ashraful I., LaRocque, Regina C., Yang, Yang, Ryan, Edward T., Qadri, Firdausi, Calderwood, Stephen B., Harris, Jason B., and Jr.Longini, Ira M.
- Subjects
VIBRIO cholerae ,BACTERIAL disease transmission ,VIBRIONACEAE ,WATER pollution ,FOOD contamination ,URBAN health - Abstract
Background: Vibrio cholerae infections cluster in households. This study's objective was to quantify the relative contribution of direct, within-household exposure (for example, via contamination of household food, water, or surfaces) to endemic cholera transmission. Quantifying the relative contribution of direct exposure is important for planning effective prevention and control measures. Methodology/Principal Findings: Symptom histories and multiple blood and fecal specimens were prospectively collected from household members of hospital-ascertained cholera cases in Bangladesh from 2001–2006. We estimated the probabilities of cholera transmission through 1) direct exposure within the household and 2) contact with community-based sources of infection. The natural history of cholera infection and covariate effects on transmission were considered. Significant direct transmission (p-value<0.0001) occurred among 1414 members of 364 households. Fecal shedding of O1 El Tor Ogawa was associated with a 4.9% (95% confidence interval: 0.9%–22.8%) risk of infection among household contacts through direct exposure during an 11-day infectious period (mean length). The estimated 11-day risk of O1 El Tor Ogawa infection through exposure to community-based sources was 2.5% (0.8%–8.0%). The corresponding estimated risks for O1 El Tor Inaba and O139 infection were 3.7% (0.7%–16.6%) and 8.2% (2.1%–27.1%) through direct exposure, and 3.4% (1.7%–6.7%) and 2.0% (0.5%–7.3%) through community-based exposure. Children under 5 years-old were at elevated risk of infection. Limitations of the study may have led to an underestimation of the true risk of cholera infection. For instance, available covariate data may have incompletely characterized levels of pre-existing immunity to cholera infection. Transmission via direct exposure occurring outside of the household was not considered. Conclusions: Direct exposure contributes substantially to endemic transmission of symptomatic cholera in an urban setting. We provide the first estimate of the transmissibility of endemic cholera within prospectively-followed members of households. The role of direct transmission must be considered when planning cholera control activities. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
42. Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti.
- Author
-
Charles, Richelle C., Hilaire, Isabelle J., Mayo-Smith, Leslie M., Teng, Jessica E., Jerome, J. Gregory, Franke, Molly F., Saha, Amit, Yu, Yanan, Kováč, Paul, Calderwood, Stephen B., Ryan, Edward T., LaRocque, Regina C., Almazor, Charles P., Qadri, Firdausi, Ivers, Louise C., and Harris, Jason B.
- Subjects
ANTIGEN receptors ,CHOLERA vaccines ,IMMUNOGLOBULINS ,GLOBULINS - Abstract
Background: Studies of the immunogenicity of the killed bivalent whole cell oral cholera vaccine, Shanchol, have been performed in historically cholera-endemic areas of Asia. There is a need to assess the immunogenicity of the vaccine in Haiti and other populations without historical exposure to Vibrio cholerae. Methodology/Principal Findings: We measured immune responses after administration of Shanchol, in 25 adults, 51 older children (6–17 years), and 47 younger children (1–5 years) in Haiti, where cholera was introduced in 2010. A≥4-fold increase in vibriocidal antibody titer against V. cholerae O1 Ogawa was observed in 91% of adults, 74% of older children, and 73% of younger children after two doses of Shanchol; similar responses were observed against the Inaba serotype. A≥2-fold increase in serum O-antigen specific polysaccharide IgA antibody levels against V. cholerae O1 Ogawa was observed in 59% of adults, 45% of older children, and 61% of younger children; similar responses were observed against the Inaba serotype. We compared immune responses in Haitian individuals with age- and blood group-matched individuals from Bangladesh, a historically cholera-endemic area. The geometric mean vibriocidal titers after the first dose of vaccine were lower in Haitian than in Bangladeshi vaccinees. However, the mean vibriocidal titers did not differ between the two groups after the second dose of the vaccine. Conclusions/Significance: A killed bivalent whole cell oral cholera vaccine, Shanchol, is highly immunogenic in Haitian adults and children. A two-dose regimen may be important in Haiti, and other populations lacking previous repeated exposures to V. cholerae. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
43. Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide.
- Author
-
Alam, Mohammad Murshid, Bufano, Megan Kelly, Xu, Peng, Kalsy, Anuj, Yu, Y., Freeman, Y. Wu, Sultana, Tania, Rashu, Md. Rasheduzzaman, Desai, Ishaan, Eckhoff, Grace, Leung, Daniel T., Charles, Richelle C., LaRocque, Regina C., Harris, Jason B., Clements, John D., Calderwood, Stephen B., Qadri, Firdausi, Vann, W. F., Kováč, Pavol, and Ryan, Edward T.
- Subjects
CHOLERA vaccines ,VIBRIO cholerae ,POLYSACCHARIDES ,ESCHERICHIA coli toxins ,IMMUNOLOGIC memory - Abstract
Background: Protective immunity against cholera is serogroup specific. Serogroup specificity in Vibrio cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. Methodology: Here we report the evaluation in mice of a conjugate vaccine for cholera (OSP:TThc) made from V. cholerae O1 Ogawa O-Specific Polysaccharide–core (OSP) and recombinant tetanus toxoid heavy chain fragment (TThc). We immunized mice intramuscularly on days 0, 21, and 42 with OSP:TThc or OSP only, with or without dmLT, a non-toxigenic immunoadjuvant derived from heat labile toxin of Escherichia coli. Principal Findings: We detected significant serum IgG antibody responses targeting OSP following a single immunization in mice receiving OSP:TThc with or without adjuvant. Anti-LPS IgG responses were detected following a second immunization in these cohorts. No anti-OSP or anti-LPS IgG responses were detected at any time in animals receiving un-conjugated OSP with or without immunoadjuvant, and in animals receiving immunoadjuvant alone. Responses were highest following immunization with adjuvant. Serum anti-OSP IgM responses were detected in mice receiving OSP:TThc with or without immunoadjuvant, and in mice receiving unconjugated OSP. Serum anti-LPS IgM and vibriocidal responses were detected in all vaccine cohorts except in mice receiving immunoadjuvant alone. No significant IgA anti-OSP or anti-LPS responses developed in any group. Administration of OSP:TThc and adjuvant also induced memory B cell responses targeting OSP and resulted in 95% protective efficacy in a mouse lethality cholera challenge model. Conclusion: We describe a protectively immunogenic cholera conjugate in mice. Development of a cholera conjugate vaccine could assist in inducing long-term protective immunity, especially in young children who respond poorly to polysaccharide antigens. Author Summary: Cholera is a severe dehydrating diarrheal illness of humans caused by organisms Vibrio cholerae serogroups O1 or O139 serogroup organisms. Protective immunity against cholera is serogroup specific. Serogroup specificity in V. cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. Unfortunately, children bear a large burden of cholera globally. Here we describe a novel cholera conjugate vaccine and show that it induces immune responses in mice, including memory responses, to OSP, the T cell-independent antigen that probably is the target of protective immunity to cholera. These responses were highest following immunization of the vaccine with a novel immunoadjuvant, dmLT. We also show that immunization of mice with this conjugate vaccine protects against challenge with wild-type V. cholerae. A protectively immunogenic cholera conjugate vaccine that induces long-term memory responses could have particular utility in young children who are most at risk of cholera. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
44. Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide.
- Author
-
Alam, Mohammad Murshid, Bufano, Megan Kelly, Xu, Peng, Kalsy, Anuj, Yu, Y., Freeman, Y. Wu, Sultana, Tania, Rashu, Md. Rasheduzzaman, Desai, Ishaan, Eckhoff, Grace, Leung, Daniel T., Charles, Richelle C., LaRocque, Regina C., Harris, Jason B., Clements, John D., Calderwood, Stephen B., Qadri, Firdausi, Vann, W. F., Kováč, Pavol, and Ryan, Edward T.
- Subjects
MICE ,VACCINATION ,VIBRIO cholerae ,POLYSACCHARIDES ,IMMUNOTHERAPY - Abstract
Background: Protective immunity against cholera is serogroup specific. Serogroup specificity in Vibrio cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. Methodology: Here we report the evaluation in mice of a conjugate vaccine for cholera (OSP:TThc) made from V. cholerae O1 Ogawa O-Specific Polysaccharide–core (OSP) and recombinant tetanus toxoid heavy chain fragment (TThc). We immunized mice intramuscularly on days 0, 21, and 42 with OSP:TThc or OSP only, with or without dmLT, a non-toxigenic immunoadjuvant derived from heat labile toxin of Escherichia coli. Principal Findings: We detected significant serum IgG antibody responses targeting OSP following a single immunization in mice receiving OSP:TThc with or without adjuvant. Anti-LPS IgG responses were detected following a second immunization in these cohorts. No anti-OSP or anti-LPS IgG responses were detected at any time in animals receiving un-conjugated OSP with or without immunoadjuvant, and in animals receiving immunoadjuvant alone. Responses were highest following immunization with adjuvant. Serum anti-OSP IgM responses were detected in mice receiving OSP:TThc with or without immunoadjuvant, and in mice receiving unconjugated OSP. Serum anti-LPS IgM and vibriocidal responses were detected in all vaccine cohorts except in mice receiving immunoadjuvant alone. No significant IgA anti-OSP or anti-LPS responses developed in any group. Administration of OSP:TThc and adjuvant also induced memory B cell responses targeting OSP and resulted in 95% protective efficacy in a mouse lethality cholera challenge model. Conclusion: We describe a protectively immunogenic cholera conjugate in mice. Development of a cholera conjugate vaccine could assist in inducing long-term protective immunity, especially in young children who respond poorly to polysaccharide antigens. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
45. Pre-Exposure Rabies Vaccination among US International Travelers: Findings from the Global TravEpiNet Consortium.
- Author
-
Dolan, Samantha B., Jentes, Emily S., Sotir, Mark J., Han, Pauline, Blanton, Jesse D., Rao, Sowmya R., LaRocque, Regina C., and Ryan, Edward T.
- Subjects
RABIES vaccines ,TRAVELERS ,CONSORTIA ,MULTIVARIABLE control systems ,DENTAL prophylaxis - Abstract
Background: People who travel to areas with high rabies endemicity and have animal contact are at increased risk for rabies exposure. We examined characteristics of international travelers queried regarding rabies vaccination during pretravel consultations at Global TravEpiNet (GTEN) practices during 2009-2010. Material and Methods: We performed bivariate and multivariable analyses of data collected from 18 GTEN clinics. Travel destinations were classified by strength level of rabies vaccination recommendation. Results: Of 13,235 travelers, 226 (2%) reported previous rabies vaccination, and 406 (3%) received rabies vaccine at the consultation. Common travel purposes for these 406 travelers were leisure (26%), research/education (17%), and nonmedical service work (14%). Excluding the 226 who were previously vaccinated, 8070 (62%) of 13,009 travelers intended to visit one or more countries with a strong recommendation for rabies vaccination; 1675 (21%) of these 8070 intended to travel for 1 month or more. Among these 1675 travelers, 145 (9%) were vaccinated, 498 (30%) declined vaccination, 832 (50%) had itineraries that clinicians determined did not indicate vaccination, and 200 (12%) remained unvaccinated for other reasons. In both bivariate and multivariate analyses, travelers with trip durations >6 months versus 1-3 months (adjusted odds ratio [OR]=4.9 [95% confidence interval [CI] 2.1, 11.4]) and those traveling for 'research/education' or to 'provide medical care' (adjusted OR=5.1 [95% CI 1.9, 13.7] and 9.5 [95% CI 2.2, 40.8], respectively), compared with leisure travelers, were more likely to receive rabies vaccination. Conclusions: Few travelers at GTEN clinics received rabies vaccine, although many planned trips 1 month long or more to a strong-recommendation country. Clinicians often determined that vaccine was not indicated, and travelers often declined vaccine when it was offered. The decision to vaccinate should take into account the strength of the vaccine recommendation at the destination country, duration of stay, availability of postexposure prophylaxis, potential for exposure to animals, and likelihood of recurrent travel to high-risk destinations. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
46. Economics of Malaria Prevention in US Travelers to West Africa.
- Author
-
Adachi, Kenji, Coleman, Margaret S., Khan, Nomana, Jentes, Emily S., Arguin, Paul, Rao, Sowmya R., LaRocque, Regina C., Sotir, Mark J., Brunette, Gary, Ryan, Edward T., and Meltzer, Martin I.
- Subjects
MALARIA prevention ,MEDICAL care costs ,TRAVELERS ,PUBLIC health ,VACCINATION ,CHEMOPREVENTION - Abstract
Costs and benefits of malaria prevention are provided during domestic pretravel health consultations. Healthcare payers always, and travelers often, save money when travelers adhere to malaria recommendations and prophylactic regimens in West Africa, especially for longer durations of travel.Background. Pretravel health consultations help international travelers manage travel-related illness risks through education, vaccination, and medication. This study evaluated costs and benefits of that portion of the health consultation associated with malaria prevention provided to US travelers bound for West Africa.Methods. The estimated change in disease risk and associated costs and benefits resulting from traveler adherence to malaria chemoprophylaxis were calculated from 2 perspectives: the healthcare payer's and the traveler's. We used data from the Global TravEpiNet network of US travel clinics that collect de-identified pretravel data for international travelers. Disease risk and chemoprophylaxis effectiveness were estimated from published medical reports. Direct medical costs were obtained from the Nationwide Inpatient Sample and published literature.Results. We analyzed 1029 records from January 2009 to January 2011. Assuming full adherence to chemoprophylaxis regimens, consultations saved healthcare payers a per-traveler average of $14 (9-day trip) to $372 (30-day trip). For travelers, consultations resulted in a range of net cost of $20 (9-day trip) to a net savings of $32 (30-day trip). Differences were mostly driven by risk of malaria in the destination country.Conclusions. Our model suggests that healthcare payers save money for short- and longer-term trips, and that travelers save money for longer trips when travelers adhere to malaria recommendations and prophylactic regimens in West Africa. This is a potential incentive to healthcare payers to offer consistent pretravel preventive care to travelers. This financial benefit complements the medical benefit of reducing the risk of malaria. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
47. Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium.
- Author
-
Hagmann, Stefan, LaRocque, Regina C., Rao, Sowmya R., Jentes, Emily S., Sotir, Mark J., Brunette, Gary, and Ryan, Edward T.
- Subjects
TRAVEL with children ,TRAVEL hygiene ,INTERNATIONAL travel ,COMMUNICABLE diseases in children ,PEDIATRIC research - Abstract
Background Children frequently travel internationally. Health-related data on such children are limited. We sought to investigate the demographics, health characteristics, and preventive interventions of outbound US international pediatric travelers. Methods We analyzed data from 32 099 travelers presenting for pre-travel healthcare at the Global TravEpiNet (GTEN), a national consortium of 19 travel clinics, from January 1, 2009 to June 6, 2012. Results A total of 3332 (10%) of all GTEN travelers were children (<18 years of age). These children traveled mostly for leisure (36%) or to visit friends or relatives (VFR) (36%). Most popular destination regions were Africa (41%), Southeast Asia (16%), Central America (16%), and the Caribbean (16%). Compared with children traveling for leisure, VFR children were more likely to present <14 days before departure for pre-travel consultation (44% vs 28%), intended to travel for 28 days or longer (70% vs 22%), and to travel to Africa (62% vs 32%). Nearly half of the pediatric travelers (46%) received at least 1 routine vaccine, and most (83%) received at least 1 travel-related vaccine. Parents or guardians of one third of the children (30%) refused at least 1 recommended travel-related vaccine. Most pediatric travelers visiting a malaria-endemic country (72%) received a prescription for malaria chemoprophylaxis. Conclusions Ten percent of travelers seeking pre-travel healthcare at GTEN sites are children. VFR-travel, pre-travel consultation close to time of departure, and refusal of recommended vaccines may place children at risk for travel-associated illness. Strategies to engage pediatric travelers in timely, pre-travel care and improve acceptance of pre-travel healthcare interventions are needed. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
48. Identification of Immunogenic Salmonella enterica Serotype Typhi Antigens Expressed in Chronic Biliary Carriers of S. Typhi in Kathmandu, Nepal.
- Author
-
Charles, Richelle C., Sultana, Tania, Alam, Mohammad Murshid, Yu, Yanan, Wu-Freeman, Ying, Bufano, Meagan Kelly, Rollins, Sean M., Tsai, Lillian, Harris, Jason B., LaRocque, Regina C., Leung, Daniel T., Brooks, W. Abdullah, Nga, Tran Vu Thieu, Dongol, Sabina, Basnyat, Buddha, Calderwood, Stephen B., Farrar, Jeremy, Khanam, Farhana, Gunn, John S., and Qadri, Firdausi
- Subjects
HUMAN immunogenetics ,SALMONELLA enterica serovar Typhi ,ANTIGENS ,BILIOUS diseases & biliousness ,DISEASE susceptibility ,TYPHOID fever ,MEMBRANE proteins ,LIPOPROTEINS - Abstract
Background: Salmonella enterica serotype Typhi can colonize and persist in the biliary tract of infected individuals, resulting in a state of asymptomatic chronic carriage. Chronic carriers may act as persistent reservoirs of infection within a community and may introduce infection to susceptible individuals and new communities. Little is known about the interaction between the host and pathogen in the biliary tract of chronic carriers, and there is currently no reliable diagnostic assay to identify asymptomatic S. Typhi carriage. Methodology/Principal Findings: To study host-pathogen interactions in the biliary tract during S. Typhi carriage, we applied an immunoscreening technique called in vivo-induced antigen technology (IVIAT), to identify potential biomarkers unique to carriers. IVIAT identifies humorally immunogenic bacterial antigens expressed uniquely in the in vivo environment, and we hypothesized that S. Typhi surviving in the biliary tract of humans may express a distinct antigenic profile. Thirteen S. Typhi antigens that were immunoreactive in carriers, but not in healthy individuals from a typhoid endemic area, were identified. The identified antigens included a number of putative membrane proteins, lipoproteins, and hemolysin-related proteins. YncE (STY1479), an uncharacterized protein with an ATP-binding motif, gave prominent responses in our screen. The response to YncE in patients whose biliary tract contained S. Typhi was compared to responses in patients whose biliary tract did not contain S. Typhi, patients with acute typhoid fever, and healthy controls residing in a typhoid endemic area. Seven of 10 (70%) chronic carriers, 0 of 8 bile culture-negative controls (0%), 0 of 8 healthy Bangladeshis (0%), and 1 of 8 (12.5%) Bangladeshis with acute typhoid fever had detectable anti-YncE IgG in blood. IgA responses were also present. Conclusions/Significance: Further evaluation of YncE and other antigens identified by IVIAT could lead to the development of improved diagnostic assays to identify asymptomatic S. Typhi carriers. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
49. Natural Selection in a Bangladeshi Population from the Cholera-Endemic Ganges River Delta.
- Author
-
Karlsson, Elinor K., Harris, Jason B., Tabrizi, Shervin, Rahman, Atiqur, Shlyakhter, Ilya, Patterson, Nick, O'Dushlaine, Colm, Schaffner, Stephen F., Gupta, Sameer, Chowdhury, Fahima, Sheikh, Alaullah, Ok Sarah Shin, Ellis, Crystal, Becker, Christine E., Stuart, Lynda M., Calderwood, Stephen B., Ryan, Edward T., Qadri, Firdausi, Sabeti, Pardis C., and LaRocque, Regina C.
- Published
- 2013
- Full Text
- View/download PDF
50. In the clinic. Travel medicine.
- Author
-
Schwartz BS, Larocque RC, Ryan ET, Schwartz, Brian S, Larocque, Regina C, and Ryan, Edward T
- Subjects
PREVENTION of bites & stings ,ENVIRONMENTALLY induced diseases ,TRAFFIC safety ,PREVENTION of communicable diseases ,COUNSELING ,HEALTH status indicators ,IMMUNIZATION ,INSECTS ,PATIENT education ,RESEARCH funding ,RISK assessment ,TRAVEL hygiene ,PREVENTION - Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.